Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy

NCT04684511 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
2
Enrollment
INDUSTRY
Sponsor class

Stopped Low enrollment. The termination of the trial was not based on any safety concerns in the study.

Conditions

Interventions

Sponsor

Tremeau Pharmceuticals, Inc.